3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Dermatologic
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
48
Multiple Myeloma
39
Lymphoma, Large B-Cell, Diffuse
38
Burkitt Lymphoma
34
Lymphoma
31
Leukemia, Myeloid, Acute
31
Lymphoma, Non-Hodgkin
29
Recurrence
27
Breast Neoplasms
27
Neoplasms
23
Lymphoma, B-Cell
23
Myelodysplastic Syndromes
22
Leukemia, Lymphocytic, Chronic, B-Cell
22
Lymphoma, Follicular
20
Hodgkin Disease
18
Triple Negative Breast Neoplasms
17
Melanoma
17
Leukemia
17
Ovarian Neoplasms
16
Hematologic Neoplasms
15
Neuroblastoma
14
Lymphoma, Mantle-Cell
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
12
Pancreatic Neoplasms
12
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
12
Leukemia, Biphenotypic, Acute
11
Neoplasm Metastasis
10
Lymphoma, B-Cell, Marginal Zone
10
Leukemia, Myelomonocytic, Chronic
10
Sarcoma
9
Interventions
Imatinib Mesylate
6
Sunitinib
4
ripretinib
2
regorafenib
2
Specimen Handling
2
Paclitaxel
2
Magnetic Resonance Spectroscopy
2
IDRX-42
2
trastuzumab deruxtecan
1
pemigatinib
1
olverembatinib
1
envafolimab
1
atezolizumab
1
apatinib
1
Temozolomide
1
Surgical Instruments
1
Sorafenib
1
Rogaratinib
1
Nivolumab
1
Midazolam
1
Laparoscopy
1
Ipilimumab
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
Biopsy
1
4-Aminopyridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gastrointestinal Stromal Tumors
×
Cyclophosphamide
×
90 days
×
Clear all
NCT01046487
2026-03-13
PALANGI3
Centre Oscar Lambret
Phase 1
Completed
26 enrolled